Ok, so it took me > 10 minutes to read through thi
Post# of 36537
(Total Views: 394)
Posted On: 08/04/2020 10:01:25 AM
Ok, so it took me > 10 minutes to read through this PR twice, and I am still puzzled what new I am supposed to read from this (except for the obvious NGIO CC announcement, but that would have been a one-liner message).
Everything else is just fluff, and same old, same old, or am I missing something here?
Just breaking it down bit by bit.
First paragraph? Yes, we already know that you are in contact with your chinese partners to work out details about a collaboration, to develop a swine flu 2.0 vaccine. Are these the same partners, that GNBT has agreed to work on a CV vaccine with, and they are not paying invoices that GNBT has sent them? Are we sure that they are the right guys to continue working with?
Second paragraph. For over one year GNBT has focussed its attention to bringing NGIO public ... and still hasn't been successful. What I would really like to understand is "WHAT THE HECK HAS TAKEN SO LONG??" and what is your explicit time line for it to happen now?
BTW, two dividends that were given to GNBT shareholders? I currently have not a single AE/NGIO share in my brokerage account. There were some in an out for the last couple of months. The last were removed from it again in late June.
Thirs paragraph. Excited about the opportunities that are in front of us. Either name them, or zipp it. This way it is like "I know something, I know something, this is going to be REALLY GREAT, but I cannot really talk about it yet!"
If that is the case, then keep it to yourself until you are able to give me all the details about it.
And when it comes to CV vaccine, what I would really like to know is the status of the funding applications with BARDA, Canada Health and Malaysian Health Org., but a lot of bla bla bla, but the important stuff, we AGAIN hear nothing about.
Sorry, but I am rather disappointed with the "bone that is thrown me again today by the GNBT management!" I am not sure if I'd rather not hear from the company than receive such fluff BS.
Your opinion?
Everything else is just fluff, and same old, same old, or am I missing something here?
Just breaking it down bit by bit.
First paragraph? Yes, we already know that you are in contact with your chinese partners to work out details about a collaboration, to develop a swine flu 2.0 vaccine. Are these the same partners, that GNBT has agreed to work on a CV vaccine with, and they are not paying invoices that GNBT has sent them? Are we sure that they are the right guys to continue working with?
Second paragraph. For over one year GNBT has focussed its attention to bringing NGIO public ... and still hasn't been successful. What I would really like to understand is "WHAT THE HECK HAS TAKEN SO LONG??" and what is your explicit time line for it to happen now?
BTW, two dividends that were given to GNBT shareholders? I currently have not a single AE/NGIO share in my brokerage account. There were some in an out for the last couple of months. The last were removed from it again in late June.
Thirs paragraph. Excited about the opportunities that are in front of us. Either name them, or zipp it. This way it is like "I know something, I know something, this is going to be REALLY GREAT, but I cannot really talk about it yet!"
If that is the case, then keep it to yourself until you are able to give me all the details about it.
And when it comes to CV vaccine, what I would really like to know is the status of the funding applications with BARDA, Canada Health and Malaysian Health Org., but a lot of bla bla bla, but the important stuff, we AGAIN hear nothing about.
Sorry, but I am rather disappointed with the "bone that is thrown me again today by the GNBT management!" I am not sure if I'd rather not hear from the company than receive such fluff BS.
Your opinion?
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼